Intellectual Property

  • December 05, 2024

    Gov't Efficiency Push Is A 'New Day,' House Speaker Says

    House Speaker Mike Johnson, R-La., spoke excitedly Thursday about the new government efficiency operation helmed by billionaire Elon Musk and former presidential candidate Vivek Ramaswamy and touted the budding bipartisan lineup of a congressional caucus that will work with it.

  • December 05, 2024

    Judge Snubs Bid For $1M Bond On $22M 'Comfy' IP Verdict

    An Arizona federal judge on Wednesday rejected a retailer's bid to pay a $1 million bond while appealing a $22 million judgment against it for infringing the design patents of Cozy Comfort Co., the maker of the "Comfy" sweatshirt featured on "Shark Tank."

  • December 05, 2024

    Sanctioned VLSI Patent Challenger Must ID Members In Va.

    VLSI Technology LLC won a major victory Thursday in litigation where it's looking for compensation from a mysterious company it claims tried to "extort" it at the Patent Trial and Appeal Board, with a Virginia federal judge ordering that company to disclose its members.

  • December 05, 2024

    Infringing Phone Mounts Permanently Blocked In Patent Case

    A Washington federal judge agreed on Thursday to block a maker of electronic device mounts from selling certain products that have infringed a patent owned by a rival.

  • December 05, 2024

    Face-Swapping App Can't Ax Reality TV Star's Suit At 9th Circ.

    The Ninth Circuit on Thursday refused to toss a reality TV star's proposed class action accusing a face-swapping app of misusing his likeness, finding his statutory right-of-publicity claim isn't preempted by the federal Copyright Act since the claim involves his likeness and "not a work of authorship."

  • December 05, 2024

    NCAA's NIL Settlement 'Illegal' In Many States, Lawmakers Say

    The National Collegiate Athletic Association's $2.78 billion settlement with athletes over name, image and likeness compensation, now awaiting final court approval, would be "illegal" in several states because of their current NIL laws, a group of current and former lawmakers said Thursday.

  • December 05, 2024

    Fed. Circ. Unlikely To Help Realtek Pursue ITC Sanctions

    A Federal Circuit panel seemed baffled Thursday as a K&L Gates attorney argued that the U.S. International Trade Commission wrongly stopped his client from pursuing sanctions, with the panel repeatedly noting that the semiconductor company wasn't even a party in the import dispute.

  • December 05, 2024

    9th Circ. Skeptical Starz Ripped Off Play For Strip Club Drama

    A Ninth Circuit panel appeared dubious Thursday of a playwright's bid to revive claims that Starz Entertainment copied her stage musical for the strip club drama series "P-Valley," with one of the appellate judges noting that the works "could not be more different."

  • December 05, 2024

    PrizePicks Faces Second Claim Of Fantasy Platform Ripoff

    Atlanta-based sports betting platform PrizePicks has been hit with a second lawsuit in as many years from business-to-business sports tech company Vetnos, claiming Wednesday that PrizePicks ripped off its concept of daily fantasy betting games with the help of a former Vetnos employee.

  • December 05, 2024

    Skadden Adds A&O Shearman IP Litigator In Silicon Valley

    Skadden Arps Slate Meagher & Flom LLP continues expanding its technology team, announcing Thursday it has brought in an Allen Overy Shearman Sterling intellectual property litigator as a partner in its Silicon Valley office.

  • December 05, 2024

    Fed. Circ. Backs Mixed PTAB Ruling In Circuit Patent Fight

    The Federal Circuit on Thursday affirmed the Patent Trial and Appeal Board's finding that Dutch semiconductor maker NXP was able to show that some claims in a pair of Bell Semiconductor circuit patents were invalid but was unable to prove other claims were unpatentable.

  • December 05, 2024

    Insulet Wins $452M In Trade Secret Theft Trial

    A Massachusetts federal jury has awarded Insulet Corp. $452 million after concluding that a South Korean company stole its trade secrets for a wearable insulin patch pump, marking one of the largest trade secrets verdicts of the decade.

  • December 04, 2024

    Withers IP Partners Hop To Sullivan & Worcester

    Sullivan & Worcester LLP has said the Boston firm picked up a team of five intellectual property lawyers, including two partners, from Withers who have expertise in filing patents and working on deals for biotech startups. 

  • December 04, 2024

    Intel, VLSI Agree To Pause Del. IP Fight Ahead Of Texas Trial

    Prodded by a federal judge in Delaware, Intel Corp. and VLSI Technology LLC agreed Wednesday to stay motions to dismiss or transfer an Intel Corp. suit over claims that it already holds licenses to patents that VLSI asserts it controls, as a similar patent battle moves forward in Texas.

  • December 04, 2024

    Fed. Circ. Sinks Patent Fight Over Intel's CPU Chips

    The Federal Circuit on Wednesday rubber-stamped a ruling out of Delaware federal court that cleared Intel of allegations that the chipmaker infringed patents by a University of Maryland professor who purportedly developed an important idea in the world of "parallel computing" in 2006.

  • December 04, 2024

    Novartis Fails To Stop Generic Drug Release At Fed. Circ.

    Novartis could not persuade Federal Circuit judges to grant an injunction Wednesday protecting its blockbuster heart failure medication from facing generic competition, with the appeals court backing a Delaware federal judge's opinion that it was unlikely that one of the generic drug's ingredients is "amorphous."

  • December 04, 2024

    JSR Wins As Fed. Circ. Axes Cytiva Antibody Isolation Patents

    In a precedential opinion, the Federal Circuit held Wednesday that all the claims that JSR Corp. challenged in three Cytiva Bioprocess antibody isolation patents are invalid as obvious, backing the Patent Trial and Appeal Board's invalidation of many claims while reversing its decision to uphold others.

  • December 04, 2024

    Meta Persuades PTAB To Ax 2 Earphone Patents

    The Patent Trial and Appeal Board has found that Meta was able to show that every claim in a pair of earphone patents owned by Eight kHz is invalid, holding they are obvious.

  • December 04, 2024

    Fed. Circ. Sends UC System LED Patent Claims Back To PTAB

    The Federal Circuit on Wednesday found that the Patent Trial and Appeal Board has to partially rethink its finding that claims in a filament LED light bulb patent owned by the University of California system were too obvious to warrant patent protection.

  • December 04, 2024

    Penn State Eyes Ban, Atty Fees After Trial Win Against Retailer

    The Pennsylvania State University has asked a federal court in the Keystone State to permanently block an online retailer and its owner from selling merchandise that a jury found infringed the university's trademarks, and said it is entitled to attorney fees from the "serial infringers."

  • December 04, 2024

    Fleetwood Mac Producer, Playwright Settle IP Dispute

    A producer of the 1977 Fleetwood Mac album "Rumours" and the author of the play "Stereophonic" have resolved claims that the Broadway show infringed copyrighted material from a memoir about making the record, according to a filing in New York federal court.

  • December 04, 2024

    Amazon, Stanley Tumbler Maker Sue Alleged Counterfeiters

    Amazon and the maker of the popular "Stanley" tumbler are suing several marketplace vendors in Washington federal court, accusing them of peddling counterfeit drink ware in the e-commerce platform's latest legal push to crack down on brand-stealing sellers.

  • December 04, 2024

    Ace Hardware Looks To Nail Screw-Selling Rival Over TM Use

    Ace Hardware Corp. said Tuesday that a home improvement chain sharing the Ace name is watering down its decades of name recognition and goodwill while creeping in on Ace's turf and leading confused consumers astray.

  • December 04, 2024

    Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight

    U.S. Circuit Judge Todd Hughes called the Federal Circuit's case law on interpreting preambles in patent claims "nonsense" on Wednesday, expressing frustration as a panel tried to work through whether Xencor Inc.'s antibody patent application was too broad.

  • December 04, 2024

    Fed. Circ. Backs NY Judge In Freeing Meta From Patent Suit

    The Federal Circuit on Wednesday wouldn't revive a software company's suit claiming Meta Platforms Inc. infringed patents on digital data storage and organization, agreeing with a decision that the evidence couldn't back a finding that the Meta features at issue covered all parts of the patent claims.

Expert Analysis

  • It's No Longer Enough For Firms To Be Trusted Advisers

    Author Photo

    Amid fierce competition for business, the transactional “trusted adviser” paradigm from which most firms operate is no longer sufficient — they should instead aim to become trusted partners with their most valuable clients, says Stuart Maister at Strategic Narrative.

  • Breaking Down Director Review Timing At The PTAB

    Author Photo

    Attorneys at Fish & Richardson examine the complexities of director review of a Patent Trial and Appeal Board ruling, including timelines for requests and decisions, and how these factors influence related district court cases.

  • Calif. Bill, NTIA Report Illustrate Open-Model AI Safety Debate

    Author Photo

    The National Telecommunications and Information Administration’s balanced recommendations for preventing misuse of open artificial intelligence models, contrasted with a more aggressive California bill, demonstrate an evolving regulatory debate about balancing democratic access to this powerful new technology against potential risks to the public, say Stuart Meyer and Fredrick Tsang at Fenwick.

  • Behind 3rd Circ. Ruling On College Athletes' FLSA Eligibility

    Author Photo

    The Third Circuit's decision that college athletes are not precluded from bringing a claim under the Fair Labor Standards Act raises key questions about the practical consequences of treating collegiate athletes as employees, such as Title IX equal pay claims and potential eligibility for all employment benefits, say attorneys at Debevoise.

  • Patent Lessons From 4 Federal Circuit Reversals In July

    Author Photo

    The Federal Circuit’s July reversal of four cases, all of which were Patent Trial and Appeal Board decisions, highlights lessons for patent practitioners regarding the scope of estoppel provisions, potential issues with obtaining certain substitute claims, and more, say Denise De Mory and Li Guo at Bunsow De Mory.

  • Video Game Release Highlights TM Pitfalls Of App Store

    Author Photo

    The upcoming release of poker video game Balatro in Apple's App Store underscores the tradeoff of keyword advertising and trademark protection for indie developers who, unlike corporate counterparts, lack resources but seek to maximize the reach of their game, say Parmida Enkeshafi and Simon Pulman at Pryor Cashman.

  • 5 Credibility Lessons Trial Attys Can Learn From Harris' Run

    Author Photo

    In launching a late-stage campaign for president, Vice President Kamala Harris must seize upon fresh attention from voters to establish, or reestablish, credibility — a challenge that parallels and provides takeaways for trial attorneys, says Ken Broda-Bahm at Persuasion Strategies.

  • Patent Owner Estoppel Questions In The Wake Of SoftView

    Author Photo

    The U.S. Patent and Trademark Office's seldom-litigated Rule 42.73(d)(3) on Patent Trial and Appeal Board estoppel was recently brought to the forefront in the Federal Circuit's SoftView v. Apple decision, highlighting uncertainties in this aspect of patent practice, say David Haars and Richard Crudo at Sterne Kessler.

  • Copyright Termination Opinion Departs From Long-Held Views

    Author Photo

    In Vetter v. Resnik, a federal court recently held for the first time that termination rights under Section 304 of the Copyright Act recapture domestic and foreign rights where the original grant was for "worldwide" rights — misinterpreting a basic principle of international copyright treaties, say Rebecca Benyamin and Eric J. Schwartz at Mitchell Silberberg.

  • 3 Patent Considerations For America's New Quantum Hub

    Author Photo

    Recent developments signal an incredibly bright future for Chicago as the new home of quantum computing, and it is crucial that these innovators — whose technology has the potential to transform many industries — prioritize intellectual property strategy, says Andrew Velzen at McDonnell Boehnen.

  • Fed. Circ. Ruling Creates New Rule For Certification Marks

    Author Photo

    The Federal Circuit's decision last month in Bureau National Interprofessionnel du Cognac v. Cologne & Cognac Entertainment is significant in that it establishes a new standard for assessing evidence of third-party uses of a certification mark in deciding whether the mark is famous, say Samantha Katze and Lisa Rosaya at Manatt.

  • A Preview Of AI Priorities Under The Next President

    Author Photo

    For the first time in a presidential election, both of the leading candidates and their parties have been vocal about artificial intelligence policy, offering clues on the future of regulation as AI continues to advance and congressional action continues to stall, say attorneys at Mintz.

  • 11 Patent Cases To Watch At Fed. Circ. And High Court

    Author Photo

    As we head into fall, there are 11 patent cases to monitor, touching on a range of issues that could affect patent strategy, such as biotech innovation, administrative rulemaking and patent eligibility, say Edward Lanquist and Wesley Barbee at Baker Donelson.

  • Why India May Become A Major Patent Litigation Forum

    Author Photo

    India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.

  • Opinion

    To Lower Drug Prices, Harris Must Address Patent Thickets

    Author Photo

    If Vice President Kamala Harris is serious about her pledge to address high drug prices, she must begin by closing loopholes that allow pharmaceutical companies to develop patent thickets that can deter generic or biosimilar companies from entering the market, says Tahir Amin at the Initiative for Medicines, Access & Knowledge.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!